Dun & Bradstreet Releases 2026 Ranking of Israel's Leading Venture Capital Funds
A new Dun & Bradstreet ranking for 2026 highlights Israel's leading venture capital funds across early, growth, and late stages, with Team8, Viola, and Red Dot leading their respective categories.
The Israeli venture capital ecosystem is recalibrating amid shifting market dynamics, demanding greater maturity from startups driven by artificial intelligence advancements and a strict focus on profitability by investors. A newly released Dun & Bradstreet ranking for 2026 highlights the leading Israeli venture capital funds across various stages of investment, from early rounds to late-stage growth.
In the early-stage category, Team8 secured the top position. The fund raised 365 million dollars last August and currently manages close to 2 billion dollars. Entrée Capital followed in second place, with TLV Partners taking third, Vertex Ventures Israel fourth, and CyberStarts fifth. Rounding out the top ten in this segment are Glilot Capital Partners, YL Ventures, Aleph, StageOne Ventures, and iAngels.
For early growth companies, Viola captured the leading spot, followed by OurCrowd and 83North, which recently reported approximately 400 million dollars available for new investments. Additional prominent funds in this category include Pitango, Vintage Investment Partners, JVP, Peregrine Ventures, aMoon Fund, O.G Venture Partners, and Pontifax.
In the advanced growth stages, Red Dot Capital Partners claimed first place. Qumra Capital secured second place, while Greenfield ranked third following a recent 400 million dollar fundraising round. The top ten in the advanced category concludes with IGP, FinTLV Ventures, ISF, Catalyst, ION Crossover Partners, Titan Capital Partners, and MoreTech.
The D&B methodology assessed portfolio quality, investment activity volume, portfolio company support, and historical exits. Early-stage funds were evaluated on identifying next-generation technologies, multi-stage funds on scaling potential into growth, and late-stage funds on converting expansion into commercial results and market leadership. Industry analysts note that such rankings should be viewed critically, as methodologies often favor established mega-funds, rely on self-reporting, and emphasize valuation estimates over realized returns.
